HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.
about
Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patientsStructure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypesK65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing dataTrends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment RegimensHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaClinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in NigeriaThe K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in EthiopiaDrug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South AfricaHIV Genetic Diversity and Drug Resistance.Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.Management of paediatric HIV-1 resistance.Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy.Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaDrug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectionReverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.Tackling virological failure in HIV-infected children living in Africa.Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk.Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy.International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptaseDevelopment of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1Discordance between genotypic resistance and pseudovirus phenotypic resistance in AIDS patients after long-term antiretroviral therapy and virological failure.Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1.Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.Paediatric human immunodeficiency virus treatment outcomes from a resource-limited setting in South Africa: Highly active antiretroviral therapy alone is not enough
P2860
Q21245026-824CEF47-C2BF-4D76-9F18-6A7E11EDD4ACQ27660028-5D8D014B-9C56-4670-B244-F7F2D4782330Q28483758-8EEF605F-BDFA-4011-B70C-5D00F4ED4BA0Q28534323-ABFB44BA-7393-4B94-A07B-001B45B59305Q28535483-96C984CF-CD14-41F8-99FA-F1C8C4359B06Q33625367-FE4CEB71-0FE7-44E1-BB51-4777548A1C71Q33681279-C7D8FAAD-6B8D-47BD-9624-EBB41F653353Q33714130-32074837-2F5E-4A04-967D-DB48D47031FBQ33927293-B471FB5F-3536-426F-9F86-1F773F7C4147Q33952538-35C5BE8B-DC16-4CC6-AB06-EBB72B19C75BQ34764036-DF33F3E7-66C4-4987-BC12-B765E906826EQ35105844-D910BBDB-6EDA-4D32-BA85-3E61505C34B4Q35127254-9BDFD57C-F7D1-402A-BAAB-E02945B5D6EBQ35217629-05DB8BBE-D1B5-441C-99C0-049B6FD31F61Q35260590-09A5A524-2F8C-4CAE-9B7C-8B7467A9C4AFQ35403205-0A9B8B98-CE14-4899-B9DF-CA3A617305DAQ36611206-493EBC64-C100-47AD-8274-34152C658E19Q37326138-AEDC470D-19AD-4B15-8506-88F7A381A114Q37438121-04B58AB9-A49E-4800-AF7B-4F9BFD742829Q37461877-1DD84B01-A2D1-4951-B5CA-98A1618C5C97Q37580891-DC1E861F-321E-430A-BA0C-ACAD5884A58FQ37696892-2960B79F-F4E2-487E-BA48-4BA690ED577FQ37942538-4651A6BA-6E6C-417E-B4A4-1A3D1D49D741Q38552894-FBB5FCB4-F33D-41F7-A6FC-972D98C235CDQ38898319-1DAB3313-D200-422D-B7E0-385B5F768D18Q39698651-2B098480-DF80-4230-B1BB-FF53F94C98D3Q39895796-7CAF8DFA-86B8-4090-94C4-AD2CA85E8710Q41766628-07C9BA89-98FA-4E05-AB8F-EC66E3AEDB58Q42249037-947A9E92-5E65-4A24-A5A1-D5A574114273Q42671473-95BEDF3E-4F3B-4C9A-ADBC-C155EA1E36B2Q44710836-5AEE68EE-FEC7-43D7-A44F-7AC0D1F81617Q58436199-F0A110AD-9E8E-4A4B-8204-B236E0D8BB94
P2860
HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@en
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@nl
type
label
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@en
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@nl
prefLabel
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@en
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@nl
P2093
P921
P356
P1476
HIV type 1 subtype C drug resi ...... ailing antiretroviral therapy.
@en
P2093
Candice Pillay
Francois Venter
Leon Levin
Rami Kantor
Visva Pillay
P304
P356
10.1089/AID.2008.0180
P50
P577
2008-11-01T00:00:00Z